ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹52 Cr | ₹52 Cr | ₹54 Cr | ₹28 Cr | ₹25 Cr |
What is the latest Contingent Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹52 Cr |
| Mar2025 | ₹52 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹28 Cr |
| Mar2022 | ₹25 Cr |
How is Contingent Liabilities of ERIS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹52 Cr | -0.75 | |
| Mar2025 | ₹52 Cr | -3.69 | |
| Mar2024 | ₹54 Cr | 90.05 | |
| Mar2023 | ₹28 Cr | 15.82 | |
| Mar2022 | ₹25 Cr | - | |
Compare Contingent Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,092.8 Cr | -2.2% | -3.3% | -23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -2.2% |
-3.3% |
-23.7% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses